DE602007006023D1 - Standard/referenz/kontrolle für blutgerinnungstests - Google Patents

Standard/referenz/kontrolle für blutgerinnungstests

Info

Publication number
DE602007006023D1
DE602007006023D1 DE602007006023T DE602007006023T DE602007006023D1 DE 602007006023 D1 DE602007006023 D1 DE 602007006023D1 DE 602007006023 T DE602007006023 T DE 602007006023T DE 602007006023 T DE602007006023 T DE 602007006023T DE 602007006023 D1 DE602007006023 D1 DE 602007006023D1
Authority
DE
Germany
Prior art keywords
standard
control
blood recovery
recovery tests
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007006023T
Other languages
English (en)
Inventor
Timothy Ho
James Cole
Alireza Ebrahim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Rad Laboratories Inc
Original Assignee
Bio Rad Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Laboratories Inc filed Critical Bio Rad Laboratories Inc
Publication of DE602007006023D1 publication Critical patent/DE602007006023D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00Reference solutions for assays of biological material
    • G01N2496/05Reference solutions for assays of biological material containing blood cells or plasma
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497Preparation composition [e.g., lysing or precipitation, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331Preservative, buffer, anticoagulant or diluent
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE602007006023T 2006-08-04 2007-07-24 Standard/referenz/kontrolle für blutgerinnungstests Active DE602007006023D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/462,436 US7588942B2 (en) 2006-08-04 2006-08-04 Standard/reference/control for blood coagulation testing
PCT/US2007/074191 WO2008019221A1 (en) 2006-08-04 2007-07-24 Standard/reference/control for blood coagulation testing

Publications (1)

Publication Number Publication Date
DE602007006023D1 true DE602007006023D1 (de) 2010-06-02

Family

ID=38728890

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007006023T Active DE602007006023D1 (de) 2006-08-04 2007-07-24 Standard/referenz/kontrolle für blutgerinnungstests

Country Status (9)

Country Link
US (1) US7588942B2 (de)
EP (1) EP2047280B1 (de)
JP (1) JP5074496B2 (de)
CN (1) CN101535814B (de)
AT (1) ATE465416T1 (de)
AU (1) AU2007281898B2 (de)
CA (1) CA2659622C (de)
DE (1) DE602007006023D1 (de)
WO (1) WO2008019221A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7618821B2 (en) * 2007-04-13 2009-11-17 Streck, Inc. Simulated blood components and methods
CN101762710B (zh) * 2010-01-26 2013-08-21 明德松 一种多项液体质控物及其制备方法
KR102010094B1 (ko) * 2011-04-28 2019-08-12 베크만 컬터, 인코포레이티드 연장된 안정성을 가지는 혈액학 대조 조성물
US9354144B2 (en) 2011-09-20 2016-05-31 Bio-Rad Laboratories, Inc. Customized quality controls for analytical assays
JP6514190B2 (ja) 2013-05-06 2019-05-15 バイオ−ラッド ラボラトリーズ インコーポレーティッド 参照物質における不安定な被分析物の安定化
CN104166004B (zh) * 2014-09-04 2016-01-13 中国医学科学院输血研究所 凝血因子ⅷ质控品制备方法
AU2016218254B2 (en) 2015-02-09 2019-12-19 Slingshot Biosciences, Inc. Hydrogel particles with tunable optical properties and methods for using the same
JP6605990B2 (ja) * 2016-03-02 2019-11-13 特定非営利活動法人 病態解析研究所 血液分析装置の精度管理用管理物質及びその製造方法
CN106290923B (zh) * 2016-08-01 2018-05-11 重庆鼎润医疗器械有限责任公司 一种活化凝血检测试剂及其应用
CN107102125B (zh) * 2017-04-17 2019-07-09 中国科学院苏州生物医学工程技术研究所 血栓弹力图仪的校准方法
CN108169467B (zh) * 2017-11-27 2019-09-20 中国科学院苏州生物医学工程技术研究所 一种血栓弹力图仪质控品及其制备方法和应用
JP2023529274A (ja) * 2020-04-24 2023-07-10 ペロスフィア・テクノロジーズ・インコーポレイテッド 全血対照試料系ならびに前記を調製および使用する方法
CN117741166B (zh) * 2024-02-19 2024-04-26 北京水木济衡生物技术有限公司 一种多项目复合凝血质控品及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1226795A (en) * 1983-06-06 1987-09-15 Michael K. Hoskins Stabilized coagulation control products
US4731330A (en) * 1986-07-01 1988-03-15 Biotrack, Inc. Whole blood control sample
US5939325A (en) 1989-07-20 1999-08-17 Analytical Control Systems, Inc. Stable whole blood coagulation controls
AU7137900A (en) 1999-07-23 2001-02-13 Medical Analysis Systems, Inc. Stabilized coagulation control reagent and method of making same

Also Published As

Publication number Publication date
WO2008019221A1 (en) 2008-02-14
JP5074496B2 (ja) 2012-11-14
AU2007281898A1 (en) 2008-02-14
ATE465416T1 (de) 2010-05-15
CN101535814A (zh) 2009-09-16
CN101535814B (zh) 2013-07-17
EP2047280B1 (de) 2010-04-21
AU2007281898B2 (en) 2012-11-15
US7588942B2 (en) 2009-09-15
JP2009545751A (ja) 2009-12-24
CA2659622C (en) 2014-07-08
US20080032405A1 (en) 2008-02-07
EP2047280A1 (de) 2009-04-15
CA2659622A1 (en) 2008-02-14

Similar Documents

Publication Publication Date Title
DE602007006023D1 (de) Standard/referenz/kontrolle für blutgerinnungstests
BRPI0906549A2 (pt) Bandagens médicas com válvulas e kits contendo as mesmas.
BR112012014575A2 (pt) "uso combinado de proteínas cry1da e cry1fa para gerenciamento de resistência em inseto"
BR112012014801A8 (pt) uso combinado de proteínas cry1ca e cry1fa para controle de resistência a insetos
BR112012014772A2 (pt) Uso combinado de vip3ab e cry1fa para gerenciamento de insetos resistentes
CO6410314A2 (es) Proteínas de unión a il-17
BR112012031071A2 (pt) 8-proteínas de ligação à il-1
UY30364A1 (es) Arilimidazolonas y ariltriazolonas sustituidas asi como su uso
BR112013000386A2 (pt) combinação de polímero acrílico, composição, e, métodos para mascarar uma combinação polimérica com base em acrílico, e para espessar uma composição aquosa
SV2008002980A (es) Composiciones y metodos de uso para anticuerpos de dickkopf-1 y/0 -4
MX2022013625A (es) Metodo para evaluar los efectos de una composicion que comprende microorganismos en la microbiota intestinal.
BR112012014746A2 (pt) Uso combinado de proteínas cry1ca e cry1ab para gerenciamento de resistência em inseto
BR112013003763A2 (pt) métodos e meios para a caracterização da resistência a antibióticos em microrganismos
EP1876240A4 (de) Monoklonaler antikörper gegen blutplättchenmembran-glykoprotein vi
BR112012031626A2 (pt) composição adesiva sensível á pressão para aplicação na pele, construção adesiva com camada, e, dispositivo médico
BR112014020512A8 (pt) Métodos e sistemas para a detecção de microorganismos
MY159678A (en) Bimodal neodymium-catalyzed polybutadiene
BR112012011485A2 (pt) "composições e métodos para tratar náusea e vômito centralmente mediados".
BR112012014681A2 (pt) Uso de cry1da em combinação com cry1ca para gerenciamento de insetos resistentes
BR112013012101A2 (pt) Composição estabilizada compreendendo homopolímeros ou copolímeros de etileno e antioxidantes naturais e produtos finais obtidos da referida composição
WO2007089665A3 (en) Storage-stable cellular whole blood composition containing elevated amounts of d-dimer
EP4299585A3 (de) Zusammensetzungen und verfahren für antithrombotische und hämostatische therapien
WO2010039819A3 (en) Compositions for use in identification of fungi
EA200870112A1 (ru) Новое применение полибифенилэфирсульфонов
WO2011163627A3 (en) Organ specific diagnostic panels and methods for identification of organ specific panel proteins

Legal Events

Date Code Title Description
8364 No opposition during term of opposition